Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma

Surgery (United States)

Volumn 153, Issue 2, 2013, Pages 234-241

  Baba, Yoshifumi ^a   Watanabe, Masayuki ^a   Shigaki, Hironobu ^a   Iwagami, Shiro ^a   Ishimoto, Takatsugu ^a   Iwatsuki, Masaaki ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE COUNT; LYMPH NODE DISSECTION; LYMPHATIC PARAMETERS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84872498303     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.08.001     Document Type: Article

References (34)

1. P.C. Enzinger, and R.J. Mayer Esophageal cancer N Engl J Med 349 2003 2241 2252
2. M. Kranzfelder, T. Schuster, H. Geinitz, H. Friess, and P. Buchler Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer Br J Surg 98 2011 768 783
3. E.H. Gemmill, and P. McCulloch Systematic review of minimally invasive resection for gastro-oesophageal cancer Br J Surg 94 12 2007 Dec 1461 1467
4. E.F. Courrech Staal, B.M. Aleman, H. Boot, M.L. van Velthuysen, H. van Tinteren, and J.W. van Sandick Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer Br J Surg 97 2010 1482 1496
5. M. Stahl Is there any role for surgery in the multidisciplinary treatment of esophageal cancer? Ann Oncol 21 Suppl 7 2010 vii283 vii285
6. A. Pennathur, J. Zhang, H. Chen, and J.D. Luketich The "best operation" for esophageal cancer? Ann Thorac Surg 89 2010 S2163 S2167
7. N. Ando, H. Kato, H. Igaki, M. Shinoda, S. Ozawa, and H. Shimizu A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907) Ann Surg Oncol 19 2012 68 74
8. M. Hirao, N. Ando, T. Tsujinaka, H. Udagawa, M. Yano, and H. Yamana Influence of preoperative chemotherapy for advanced thoracic oesophageal squamous cell carcinoma on perioperative complications Br J Surg 98 2011 1735 1741
9. G.G. Jamieson, P.J. Lamb, and S.K. Thompson The role of lymphadenectomy in esophageal cancer Ann Surg 250 2009 206 209
10. M. Tachibana, S. Kinugasa, N. Hirahara, and H. Yoshimura Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma Eur J Cardiothorac Surg 34 2008 427 431
11. T. Lerut, P. Nafteux, J. Moons, W. Coosemans, G. Decker, and P. De Leyn Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma Ann Surg 240 2004 962 972 discussion 72-4
12. L.J. Herrera Extent of lymphadenectomy in esophageal cancer: how many lymph nodes is enough? Ann Surg Oncol 17 2010 676 678
13. C. Mariette, and G. Piessen Oesophageal cancer: how radical should surgery be? Eur J Surg Oncol 38 2012 210 213
14. B. Kayani, E. Zacharakis, K. Ahmed, and G.B. Hanna Lymph node metastases and prognosis in oesophageal carcinoma - a systematic review Eur J Surg Oncol 37 2011 747 753
15. R.J. Korst, V.W. Rusch, E. Venkatraman, M.S. Bains, M.E. Burt, and R.J. Downey Proposed revision of the staging classification for esophageal cancer J Thorac Cardiovasc Surg 115 1998 660 669 discussion 9-70
16. T. Nishimaki, T. Suzuki, S. Suzuki, S. Kuwabara, and K. Hatakeyama Outcomes of extended radical esophagectomy for thoracic esophageal cancer J Am Coll Surg 186 1998 306 312
17. H. Akiyama, M. Tsurumaru, H. Udagawa, and Y. Kajiyama Radical lymph node dissection for cancer of the thoracic esophagus Ann Surg 220 1994 364 372 discussion 72-3
18. T.W. Rice, E.H. Blackstone, and V.W. Rusch 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction Ann Surg Oncol 17 2010 1721 1724
19. N.K. Altorki, X.K. Zhou, B. Stiles, J.L. Port, S. Paul, and P.C. Lee Total number of resected lymph nodes predicts survival in esophageal cancer Ann Surg 248 2008 221 226
20. R.E. Schwarz, and D.D. Smith Clinical impact of lymphadenectomy extent in resectable esophageal cancer J Gastrointest Surg 11 2007 1384 1393 discussion 93-4
21. A.J. Greenstein, V.R. Litle, S.J. Swanson, C.M. Divino, S. Packer, and J.P. Wisnivesky Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer Cancer 112 2008 1239 1246
22. Y. Hu, C. Hu, H. Zhang, Y. Ping, and L.Q. Chen How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Ann Surg Oncol 17 2010 784 790
23. J.D. Roder, R. Busch, H.J. Stein, U. Fink, and J.R. Siewert Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus Br J Surg 81 1994 410 413
24. C.M. Huang, J.X. Lin, C.H. Zheng, P. Li, J.W. Xie, and B.J. Lin Effect of negative lymph node count on survival for gastric cancer after curative distal gastrectomy Eur J Surg Oncol 37 2011 481 487
25. M. May, E. Herrmann, C. Bolenz, S. Brookman-May, A. Tiemann, and R. Moritz Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy Ann Surg Oncol 18 2011 2018 2025
26. S. Ogino, K. Nosho, N. Irahara, K. Shima, Y. Baba, and G.J. Kirkner Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction Am J Gastroenterol 105 2010 420 433
27. S. Ozawa, Y. Tachimori, H. Baba, M. Fujishiro, H. Matsubara, and H. Numasaki Comprehensive Registry of Esophageal Cancer in Japan Esophagus 9 2012 75 98
28. L.M. McShane, D.G. Altman, W. Sauerbrei, S.E. Taube, M. Gion, and G.M. Clark Reporting recommendations for tumor marker prognostic studies (REMARK) J Natl Cancer Inst 97 2005 1180 1184
29. H. Uno, T. Cai, M.J. Pencina, R.B. D'Agostino, and L.J. Wei On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data Stat Med 30 2011 1105 1117
30. J.B. Hulscher, J.W. van Sandick, A.G. de Boer, B.P. Wijnhoven, J.G. Tijssen, and P. Fockens Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus N Engl J Med 347 2002 1662 1669
31. J.B. Hulscher, J.G. Tijssen, H. Obertop, and J.J. van Lanschot Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis Ann Thorac Surg 72 2001 306 313
32. N.P. Rizk, H. Ishwaran, T.W. Rice, L.Q. Chen, P.H. Schipper, and K.A. Kesler Optimum lymphadenectomy for esophageal cancer Ann Surg 251 2010 46 50
33. S.B. Edge, D.R. Byrd, and C.C. Compton Esophagus and esophagogastric junction 2009 Springer New York (NY) 103 116
34. S.K. Thompson, A.R. Ruszkiewicz, G.G. Jamieson, T.R. Sullivan, and P.G. Devitt Isolated tumor cells in esophageal cancer: implications for the surgeon and the pathologist Ann Surg 252 2010 299 306